Loading...

ERIS ERIS Lifesciences Ltd Management Changes Announcement

RS L

RS

ERIS Lifesciences Ltd

(ERIS)

2025 Announcement

Volume spike clarification

Corporate Presentation

Regulatory Disclosure

Stake acquisition

Subsidiary stake acquisition

Acquisition of stake

Preferential issue

Analyst/Institutional Inves...

Analyst Call Transcript

Earnings Call Recording

Unaudited financials

Director reappointments

Investor Call Scheduled

Board Meeting Notice

Compliance Certificate

Investor Meet Intimation

Investor Meet Intimation

Show Cause Notice

Auditor Resignation

Investor Meeting

Earnings Call Transcript

Earnings Call Recording

Investor Presentation

Investor Call Scheduled

Compliance Certificate

Annual General Meeting

Annual General Meeting

Corporate Presentation

Investor Meeting

Investor Meeting

Secretarial Compliance Report

Earnings Call Transcript

Earnings Call Recording

Board Meeting Revision

Investor Presentation

Investor Meeting Scheduled

Investor Meeting

Investor Call Scheduled

Credit Rating Update

Credit Rating Update

Credit Rating Update

Credit Rating Update

Investor Meeting Scheduled

Investor Meeting

Regulatory Compliance

Corporate Guarantee

Volume Clarification

Analyst Meeting

Investor Meetings

Sale of Subsidiaries

Stake Acquisition

Investor Meet Scheduled

Debenture Redemption

Credit Facilities Avail

Corporate Guarantee

Corporate Presentation

Investor Meet Intimation

Earnings Call Transcript

Earnings Call Recording

Investor Presentation

Compliance Certificate

Investor Meeting Scheduled

Investor Meeting

Corporate Presentation

Investor Meetings Scheduled

Earnings Call Transcript

Earnings Call Recording

Stake Acquisition

Investor Presentation

100% Stake Acquisition

Investor Call Scheduled

Acquisition Closed

Regulatory Compliance

Acquisition Update

Corporate Guarantee Issued

Investor Meetings

Investor Meeting Scheduled

AGM Notification

AGM Announcement

Analyst Meetings

Analyst Meeting Scheduled

Investor Meeting Notice

Transcript Release

Earnings Conference

Acquisition Approval

Scheme Approval

Investor Presentation

Analyst Call Intimation

Analyst & Investor Meet

Certificate Submission

Analyst Meeting

Equity Allotment

Acquisition Closure

Redemption of Commercial Pa...

Loan Agreement with HDFC Bank

Corporate Presentation

Corporate Presentation

Analyst/Investor Meeting

Credit Rating Update

Compliance Report Submission

Meeting Schedule

Transcript Availability

Equity Shares Allotment

Analyst Meeting

Earnings Call Recording

Investor Presentation

Company Updates

Investor Call Intimation

Analyst Meeting Intimation

Certificate Submission

Compliance Certification An...

Equity Allotment

Compliance Certificate Subm...

Acquisition Closure

Meeting Schedule

Transcript Availability

Meeting Schedule

Conference Call Recording

Investor Presentation

Acquisition Announcement

Acquisition Announcement

Conference Call Intimation

Investor Meeting

Transcript Release

Acquisition Closure

Recording of Earnings Confe...

Investor Presentation

Board Meeting Outcome

Meeting Schedule

Credit rating assignment

Conference Call

Analyst Meeting

Investor Meeting

Meeting Schedule

Investor Meetings

Analyst/Investor Meeting

Certificate Submission

Schedule Announcement

Equity Shares Allotment

Corporate Guarantee

Schedule Announcement

Investor Meetings

Corporate Presentation

Transcript Released

Acquisition Closure

Loan Facility for Business ...

Acquisition of Nephrology a...

Investor Presentation

Acquisition of Nephrology a...

Conference Call

Certificate Confirmation

Analyst/Investor Meeting

Loan Agreement with HDFC Bank

Analyst/Investor Meeting Sc...

Meeting Schedule

Analyst/Investor Meeting

Newspaper Advertisement

Advertisement for AGM

Meeting Schedule

Analyst/Investor Meeting

Meeting Schedule

Equity Allotment

Analyst Meetings

Analyst and Investor Call

Analyst Meetings

Strategic investments

Conference Call

Analyst / Investor Meet

Equity Offerings

Financial Statements

Analyst/Institutional Inves...

Asset Acquisitions

Company Presentation

Analyst / Institutional Inv...

Investor Meeting

Transcript Release

Related Party Transactions

Rating assignment

Analyst & Investor Call

Credit Rating Assigned

External Links:

Data:

Eris Lifesciences’ board approved unaudited standalone and consolidated results for Q2 FY2025 and approved 5-year re-appointments of WTD Krishnakumar Vaidyanathan and Independent Director Kalpana Unadkat.

AI Assistant

ERIS Lifesciences Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.